China News Service, Zhengzhou, April 15 (Reporter Han Zhangyun) On April 15, the Henan Provincial Health Commission and the Henan Provincial Cancer Hospital released the "2019 Henan Cancer Registration Annual Report" (hereinafter referred to as the "Annual Report") in Zhengzhou. The annual report shows that in the tumor registration area of Henan Province, lung cancer ranks first among the top ten malignant tumors in the province.
Every year from April 15th to 21st is the National Cancer Prevention and Awareness Week. This year's theme is "Common Action on Cancer Prevention and Treatment".
Henan, the most populous province, has taken the lead in cancer follow-up registration in the Linxian area since the late 1950s. As of the end of 2019, Henan cancer follow-up registration has covered 49% of the population of the province, laying a solid foundation for cancer prevention in Henan . The "2019 Henan Cancer Registration Annual Report" reports the prevalence of malignant tumor morbidity and mortality among people in the Henan cancer registration area in 2016.
The annual report shows that the incidence of malignant tumors in the tumor registration areas of Henan Province is 268.31 per 100,000 and the mortality rate is 162.02 per 100,000; lung cancer, gastric cancer, esophageal cancer, liver cancer, breast cancer, colorectal and anal cancer, cervical cancer, and thyroid cancer , Brain and central nervous system cancer and leukemia are still the main malignant tumors in the province, accounting for about 80.71% of all malignant tumors.
Among them, the first incidence of male malignant tumors in Henan Province is lung cancer, followed by gastric cancer, esophageal cancer, liver cancer and colorectal and anal cancer; the first incidence of female malignant tumors is breast cancer, followed by lung cancer, esophageal cancer, gastric cancer and children Cervical cancer.
The top ten deaths from malignant tumors in cancer registration areas in Henan Province are lung cancer, gastric cancer, esophageal cancer, liver cancer, colorectal and anal cancer, breast cancer, brain and central nervous system cancer, cervical cancer, leukemia and pancreatic cancer, accounting for about all tumor deaths 86% of cases.
These data show that the burden of malignant tumor disease in Henan Province is still heavy, and the phenomenon of coexistence of cancer spectrum in developing countries and cancer spectrum in developed countries is present, and the prevention and control situation is grim.
At present, Henan Province has also taken a series of measures to improve the province's cancer prevention, screening and early diagnosis and treatment, standardized treatment, rehabilitation and intervention guidance.
Henan actively carried out the construction of a national cancer regional medical center, strengthened the construction of the province ’s cancer prevention and treatment system, improved the standardized management and service level of cancer diagnosis and treatment, and improved the tumor information registration and reporting system.
Henan has also formulated a systematic cancer prevention plan. By 2022 and 2030, the overall 5-year survival rate of cancer in Henan Province will be no less than 43.3% and 46.6%, respectively. By 2030, Henan will achieve full coverage of cancer registration in all counties and districts, and the number of registries included in the national cancer registration annual report shall be no less than 80. (Finish)